Kymera Therapeutics, Inc.

NASDAQ:KYMR

43.3 (USD) • At close September 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 335.81689.966120.256110.71867.61293.51109.96681.05152.38650.15268.395155.65876.91433.73347.976156.81984.90353.09831.00454.59360.97176.015
Short Term Investments 329.629373.184368.488439.252442.341427.034264.915276.774315.188346.725338.771326.25315.395387.079394.442379.567274.204280.439265.198239.24894.99415.942
Cash and Short Term Investments 665.445463.15488.744549.97509.953520.544374.881357.825367.574515.894559.494481.908392.309420.812567.605536.386359.107333.537458.733293.841155.96591.957
Net Receivables 40200.9471.3171.7042.0318.7623.7784.1223.322.5372.8822.371.2630.1351.5730.9041.7341.4330.57700
Inventory 000000000-14.673-12.25000-8.855000-162.531000
Other Current Assets 22.88217.80120.57717.42813.7514.67911.67414.09113.70611.3539.71318.46416.1829.30717.4411.5444.7955.529.4082.9462.3360.888
Total Current Assets 728.327500.951510.268568.715525.407537.253405.317375.694385.402515.894559.494494.022402.77431.382567.605543.731364.806340.791302.339297.364158.30192.845
Non-Current Assets:
Property, Plant & Equipment, Net 94.61795.90697.86499.309100.43998.665101.07991.183.18174.03613.33421.61721.92921.06611.88121.72421.76620.50210.84120.94320.28522.083
Goodwill 0000000000000000000000
Intangible Assets 0000000000000000000000
Goodwill and Intangible Assets 0000000000000000000000
Long Term Investments 303.449312.335362.159361.035198.286230.21561.43476.988104.759119.017152.328113.70190.182102.478125.18774.69245.305101.639162.531187.46400
Tax Assets 0000000000000000000000
Other Non-Current Assets 4.6759.127.7445.7831.8892.1187.9298.5968.603-95.042-122.0229.1328.548.134-98.7682.3062.5091.6211.4641.592.5231.774
Total Non-Current Assets 402.741417.361467.767466.127300.614330.998170.442176.684196.54398.01143.64144.45120.651131.67838.398.72269.58123.761184.836209.99722.80823.857
Total Assets 1,131.068918.312978.0351,034.842826.021868.251575.759552.378581.945613.905603.134638.472523.421563.06605.905642.453434.386464.552487.175507.361181.109116.702
Liabilities & Equity:
Current Liabilities:
Account Payables 5.78110.2635.9896.4946.516.8127.0754.9783.7456.4834.3356.3272.3742.5674.0055.0338.1778.3484.3683.9793.9823.276
Short Term Debt 13.66613.2413.11212.85124.8329.8912.697.197.5943.8933.9437.2387.3127.1343.5997.2646.9266.0963.2612.7333.7053.377
Tax Payables 0000000000000000000000
Deferred Revenue 4011.47613.57620.02419.25922.61337.88327.35224.30257.11463.2655.77659.4660.852101.03466.23482.26387.912170.3992.01127.28923.349
Other Current Liabilities 28.09324.0135.0927.16311.54216.82128.04323.64618.96119.30927.80521.78318.35417.78623.19915.96211.3197.78110.4368.5637.7044.568
Total Current Liabilities 87.5458.98967.76766.53262.14356.13685.69163.16654.602123.54363.2691.12487.588.339101.03494.493108.685110.137110.617107.28642.6834.57
Non-Current Liabilities:
Long Term Debt 144.09673.0974.64975.38151.5377.131156.658154.496142.528129.72813.39226.24227.2727.8114.36429.6229.68228.84414.73230.16415.39917.816
Deferred Revenue Non-Current 00003.18923.78116.76816.42120.42124.8662821.08624.07131.82339.29549.93952.67264.65477.83890.30818.98729.642
Deferred Tax Liabilities Non-Current 0000-3.189-23.781-16.7680000000-53.6590000-15.0820-17.816
Other Non-Current Liabilities 0000-75.7650-78.329-77.24-71.034-64.6270.248-12.865-13.371-13.6320.066-14.734-14.757-14.330.1-15.0820109.08
Total Non-Current Liabilities 72.04873.0974.64975.3878.954100.91295.09793.67791.91528.35749.72334.46337.9746.00145.23364.82567.59779.16892.67105.3934.386156.538
Total Liabilities 159.588132.079142.416141.912141.097157.048180.788156.843146.517151.9112.983125.587125.47134.34146.267159.318176.282189.305203.287212.67677.066191.108
Equity:
Preferred Stock 0000000000000000000507.36100
Common Stock 0.0070.0070.0070.0070.0060.0060.0060.0060.0060.0060.0060.0060.0050.0050.0050.0050.0050.0040.0040.0040.0030
Retained Earnings -896.805-820.191-754.61-683.858-621.371-579.309-530.752-516.384-463.517-424.718-383.79-348.925-305.923-265.666-228.982-195.082-166.5-141.84-128.765-116.08-108.094-76.456
Accumulated Other Comprehensive Income/Loss 0.279-0.058-1.4851.931-2.099-1.777-0.552-2.45-3.635-3.038-4.949-5.913-3.983-3.216-0.66-0.1460-0.013-0.128-0.1640.0310.006
Other Total Stockholders Equity 1,867.9991,606.4751,591.7071,574.851,308.3881,292.283926.269914.363902.574889.755878.884867.717707.852697.597689.275678.358424.599417.096412.777410.925212.1062.044
Total Shareholders Equity 971.48786.233835.619892.93684.924711.203394.971395.535435.428462.005490.151512.885397.951428.72459.638483.135258.104275.247283.888294.685104.043-74.406
Total Equity 971.48786.233835.619892.93684.924711.203394.971395.535435.428462.005490.151512.885397.951428.7200000000
Total Liabilities & Shareholders Equity 1,131.068918.312978.0351,034.842826.021868.251575.759552.378581.945613.905603.134638.472523.421563.06605.905642.453434.386464.552487.175507.361181.109116.702